NEXT day delivery available - 3pm cut off
Worldwide shipping available
Free standard UK delivery on orders over £100
This article is intended for qualified aesthetic practitioners (doctors, dentists, nurses and prescribers) and is not medical advice for patients.
PLLA filler, or poly-L-lactic acid, is not a filler in the way most practitioners first learn the word. It gives very little lasting volume on the day. Instead, it acts as a biostimulator: the microparticles set off a controlled tissue response that leads to new collagen over the following months. That single difference changes how you select patients, reconstitute the vial, inject, plan sessions and manage expectations. This guide covers each of those steps from a UK clinic's point of view, with the practical detail that rarely makes it into product brochures.
Poly-L-lactic acid is a synthetic, biocompatible and biodegradable polymer that has been used in medicine for decades, including in absorbable sutures. In aesthetics it is supplied as a freeze-dried powder of PLLA microparticles, usually with carboxymethylcellulose and mannitol as excipients, which you reconstitute into a suspension before injection.
A 2024 review of PLLA for facial rejuvenation by Ao and colleagues describes the mechanism as a subclinical foreign-body response. Macrophages and other immune cells surround the microparticles, fibroblasts are stimulated, and new collagen, mainly type I and type III, is laid down. The authors note that the immediate "fill" from the carrier fluid fades within about a week as the water is absorbed, with the collagen response building from around one month and peaking at three to six months.
For your consultation, that means one honest message: what the patient sees in the mirror straight after treatment is not the result, and it will partly disappear before the real change begins.
Hyaluronic acid (HA) gels give immediate, predictable volume and can be dissolved with hyaluronidase if something goes wrong. PLLA works slowly, builds a more diffuse result across a treatment area, and cannot be dissolved. Many experienced injectors use the two together: HA for structural support or targeted volume, PLLA for broader collagen stimulation and skin quality in areas such as the temples, lateral cheeks and lower face. The 2024 review above takes a similar view, discussing HA for deeper volumisation and PLLA for wider refinement.
Sculptra is the best-known PLLA brand and has the longest published track record, but it is not the only option. UK practitioners can now choose between several CE-marked PLLA collagen stimulators, which differ in particle size, quantity of PLLA per vial and recommended dilution. You can compare the options we stock in our PLLA stimulators collection. Whatever brand you use, the instructions for use (IFU) supplied with that product take precedence over any general protocol, including the one below.
PLLA suits patients who want gradual, natural-looking change and can commit to a course of sessions. Good candidates usually show generalised volume loss or early laxity rather than a single deep fold. Typical areas include the temples, lateral cheeks, pre-jowl sulcus and jawline, and, off-face, areas such as the décolletage or buttocks under appropriate protocols.
Be more cautious with:
Record a baseline with standardised photographs under the same lighting. Because change is slow, good photographs are the only reliable way to show patients their progress at review.
Poor reconstitution is one of the most common reasons for lumps. Clumped or under-hydrated particles distribute unevenly and concentrate in small areas, which is exactly what you want to avoid.
As one example, Galderma's published Sculptra IFU describes adding 5 ml of sterile water for injection, with up to 3 ml more (a total of 5 to 8 ml), then shaking the vial vigorously for about a minute. It states the product can be used straight away or stored for up to 72 hours, and must be discarded if not used within 72 hours of reconstitution. Other PLLA products use different volumes and hydration times, so always check the leaflet in the box.
Practical points that help regardless of brand:
The Sculptra IFU specifies injection into the deep dermis or subcutaneous layer, using a 25G or 26G needle. Many trained injectors also use a cannula for fanning in the subcutaneous plane, which can help to spread product evenly over a broad area. If you work with cannulas, our cannula range includes a choice of gauges and lengths. Superficial placement in the dermis is a recognised cause of visible papules, so stay deep enough and avoid thin-skinned zones.
Small aliquots spread widely give the most even result. The same IFU limits each individual injection to 0.1 to 0.2 ml, spaced 0.5 to 1 cm apart. Linear retrograde threading and fanning from a single entry point are both widely taught. The key is consistency: avoid depositing a bolus, and do not try to "finish" a correction in one session.
Post-treatment massage helps disperse the suspension. Galderma's IFU recommends that the patient massages the treated areas for five minutes, five times a day, for five days, often shortened to the "rule of fives". Give patients written aftercare that explains this, along with the normal advice about swelling, bruising and when to contact the clinic.
Because the response is gradual, PLLA is planned as a course rather than a single appointment. The IFU states that patients should be reassessed no sooner than four weeks after treatment before deciding on further correction. In practice, many protocols use two to three sessions spaced four to six weeks apart, with the number of vials guided by the area, the degree of volume loss and the patient's age and tissue quality.
Set expectations in writing. A useful framing for consent is: early swelling will settle within days, visible improvement usually develops gradually over the following months, and the final outcome varies between individuals. Avoid promising a fixed result or duration. Published literature describes collagen effects lasting two years or longer in some patients, but you should present this as a possibility reported in studies, not a guarantee.
The most discussed adverse events with PLLA are papules and nodules. The 2024 review notes that reported rates of nodules and granulomas across older studies range widely, from 1% to 44%, and that rates have fallen as reconstitution and injection techniques have improved. Common contributing factors include low dilution, superficial placement, injection into mobile areas and inadequate massage.
Other points to plan for in your complication protocol:
Document batch numbers for every vial used, and make sure your indemnity insurance explicitly covers biostimulator treatments before you add them to your menu.
Unlike many HA products, PLLA powder is usually stored at controlled room temperature (the Sculptra IFU states 15 to 30°C, away from heat), which simplifies storage. Check each brand's leaflet, keep stock rotated by expiry date, and buy only from suppliers that can show a clear, legitimate supply chain. If you are introducing PLLA for the first time, starting with a single established product such as aesPlla (1 x 365mg) or Sculptra (2 x 5ml vials) lets you build a consistent reconstitution and injection routine before comparing alternatives.
Formal, hands-on training in biostimulators is strongly recommended before you treat patients, even if you are an experienced HA injector. The technique, timelines and complication profile are different enough to justify it.
Most HA fillers create immediate volume with a gel that can be dissolved. PLLA gives a short-lived fill from the carrier fluid, then stimulates the patient's own collagen production over several months. It cannot be reversed with hyaluronidase.
Sculptra is a brand of injectable poly-L-lactic acid. PLLA is the material; several CE-marked products now use it, with differences in particle characteristics, vial size and recommended reconstitution.
Studies report collagen effects lasting two years or longer in some patients, but longevity varies with age, lifestyle, area treated and the number of sessions. Present duration as a range, not a promise.
Expected effects include swelling, bruising and tenderness. The main product-specific risk is papules and nodules, which are linked to dilution, depth, area and massage. Vascular events are rare but possible with any injectable and must be covered in your emergency protocol.
Many protocols use two to three sessions at intervals of at least four weeks, with the total depending on the area and degree of volume loss. Reassess at each visit rather than committing to a fixed number in advance.
PLLA filler rewards practitioners who are methodical. Careful patient selection, unhurried reconstitution, deep placement in small aliquots, a clear massage routine and a planned course all reduce the risk of nodules and help results look natural. Treat it as a separate skill from HA filler, follow the IFU for the specific product you use, and set honest expectations from the first consultation.
